MiNK Therapeutics (INKT) news
Recent news
Inwit rises 8.9% on Tradegate vs Milan close
AInvest Wire · 1d agoMink Therapeutics selected for ARPA-H-funded initiative to advance room-temperature cell therapy
Mink Therapeutics has been selected to participate in an initiative funded by the Advanced Research Projects Agency for Health (ARPA-H), aimed at advancing room-temperature cell therapy . This development is part of a broader effort to reduce logistical barriers in cell therapy delivery, which…
AInvest Wire · Sep 30, 2026Saga Furs OyJ - Sells entire offering of 3.9 mln mink pelts at auction
Saga Furs OyJ has successfully sold its entire offering of 3.9 million mink pelts at an auction, marking a significant development in the fur industry. The auction, which took place recently, attracted strong interest from buyers, resulting in the full sale of the company’s inventory. This outcome…
AInvest Wire · Sep 23, 2026Mink Therapeutics to report second quarter 2026 financial results, provide clinical updates on Agent-797 in lung injury, and highlight important business updates
MiNK Therapeutics (NASDAQ: INKT) announced on August 6, 2026, that it will report its second quarter 2026 financial results and provide clinical updates on agenT-797, its lead allogeneic invariant natural killer T (iNKT) cell therapy, in the treatment of acute lung injury . The company will also…
AInvest Wire · Aug 6, 2026Mink Ventures Corporation initiates drill program at Warren Ni Cu Co project; stakes additional claims at its Montcalm Ni Cu Co project; and terminates private placement
Mink Ventures Corporation (TSXV:MINK) has initiated a diamond drill program at its Warren Ni Cu Co project, marking a key step in the company’s exploration strategy for critical minerals. The drilling is expected to evaluate high-priority targets identified following the release of new airborne…
AInvest Wire · Jun 18, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.